← Back to Clinical Trials
Recruiting NCT06806761

NCT06806761 Tracking Balance and Walking Recovery After Stroke

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06806761
Status Recruiting
Phase
Sponsor Vrije Universiteit Brussel
Condition Stroke
Study Type OBSERVATIONAL
Enrollment 100 participants
Start Date 2025-01-07
Primary Completion 2028-12-09

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Longitudinal prospective cohort study

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 100 participants in total. It began in 2025-01-07 with a primary completion date of 2028-12-09.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to understand how balance and walking abilities recover after a stroke, using innovative tools like an interactive assessment game. By observing patients over time, the investigators seek to identify recovery patterns that can improve rehabilitation strategies tailored to individual needs. Interacting with a game designed to assess balance and movement, participants will perform tasks involving sitting balance, standing balance, and gait initiation. The game measures aspects like reaction time, movement accuracy, and postural control, providing detailed insights into recovery progress. These data will validate prediction models to support personalized care. The study is non-invasive, does not interfere with usual care, and prioritizes patient safety. The investigators' ultimate goal is to enhance the understanding of recovery, leading to better care and improved quality of life for stroke survivors.

Eligibility Criteria

Inclusion Criteria: * Adult aged ≥18 years * Diagnosis of a supratentorial ischaemic or haemorrhagic stroke * Within the first eight weeks after stroke onset at the time of inclusion * Able to understand and perform the study procedures that are feasible at a given assessment time point, based on the advice of the treating therapist(s) and/or physician(s) * Written informed consent provided by the participant or, where applicable, by a legally authorised representative Exclusion Criteria: * Neurological or orthopaedic comorbidities unrelated to stroke that significantly impair motor function * Severe medical conditions that could compromise safety during the assessments * Major deficits in communication, memory or understanding that prevent participation in the study procedures * Insufficient comprehension of Dutch, French, German or English

Contact & Investigator

Central Contact

Eva Swinnen

✉ eva.swinnen@vub.be

📞 +32 (0)2 477 44 20

Frequently Asked Questions

Who can join the NCT06806761 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06806761 currently recruiting?

Yes, NCT06806761 is actively recruiting participants. Contact the research team at eva.swinnen@vub.be for enrollment information.

Where is the NCT06806761 trial being conducted?

This trial is being conducted at Sint-Pieters-Leeuw, Belgium.

Who is sponsoring the NCT06806761 clinical trial?

NCT06806761 is sponsored by Vrije Universiteit Brussel. The trial plans to enroll 100 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology